Skip to main content

Peer Review reports

From: Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

Original Submission
16 Jun 2008 Submitted Original manuscript
14 Sep 2008 Reviewed Reviewer Report - Hubert Blum
17 Sep 2008 Reviewed Reviewer Report - Andrew Vickers
14 Oct 2008 Author responded Author comments - Katrin Hoffmann
Resubmission - Version 2
14 Oct 2008 Submitted Manuscript version 2
18 Oct 2008 Reviewed Reviewer Report - Hubert Blum
3 Nov 2008 Reviewed Reviewer Report - Andrew Vickers
10 Nov 2008 Author responded Author comments - Katrin Hoffmann
Resubmission - Version 3
10 Nov 2008 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
24 Nov 2008 Author responded Author comments - Katrin Hoffmann
Resubmission - Version 5
24 Nov 2008 Submitted Manuscript version 5
Publishing
26 Nov 2008 Editorially accepted
26 Nov 2008 Article published 10.1186/1471-2407-8-349

You can find further information about peer review here.

Back to article page